These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6298906)

  • 1. In vitro and in vivo ACTH-releasing activity of ovine CRF, sauvagine and urotensin I.
    Rivier C; Rivier J; Lederis K; Vale W
    Regul Pept; 1983 Jan; 5(2):139-43. PubMed ID: 6298906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortisol inhibits the ACTH-releasing activity of urotensin I, CRF and sauvagine observed with superfused goldfish pituitary cells.
    Fryer J; Lederis K; Rivier J
    Peptides; 1984; 5(5):925-30. PubMed ID: 6095221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urotensin I, a CRF-like neuropeptide, stimulates acth release from the teleost pituitary.
    Fryer J; Lederis K; Rivier J
    Endocrinology; 1983 Dec; 113(6):2308-10. PubMed ID: 6315348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACTH-releasing activity of urotensin I and ovine CRF: interactions with arginine vasotocin, isotocin and arginine vasopressin.
    Fryer J; Lederis K; Rivier J
    Regul Pept; 1985 May; 11(1):11-5. PubMed ID: 2989979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amunine (ovine CRF), urotensin I and sauvagine, three structurally-related peptides, produce selective dilation of the mesenteric circulation.
    MacCannell KL; Lederis K; Hamilton PL; Rivier J
    Pharmacology; 1982; 25(2):116-20. PubMed ID: 6982480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of corticotropin-releasing factor, arginine vasopressin, and related neuropeptides on the secretion of ACTH and alpha-MSH by frog anterior pituitary cells and neurointermediate lobes in vitro.
    Tonon MC; Cuet P; Lamacz M; Jégou S; Côté J; Gouteaux L; Ling N; Pelletier G; Vaudry H
    Gen Comp Endocrinol; 1986 Mar; 61(3):438-45. PubMed ID: 3007273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the behavioral effects of CRF, sauvagine and urotensin I.
    Britton DR; Hoffman DK; Lederis K; Rivier J
    Brain Res; 1984 Jun; 304(2):201-5. PubMed ID: 6611193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRF, urotensin I, and sauvagine stimulate the release of POMC-derived peptides from goldfish neurointermediate lobe cells.
    Tran TN; Fryer JN; Lederis K; Vaudry H
    Gen Comp Endocrinol; 1990 Jun; 78(3):351-60. PubMed ID: 2161377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the thermogenic effects of CRF, sauvagine and urotensin I in the rat.
    Le Feuvre RA; Rothwell NJ; White A
    Horm Metab Res; 1989 Sep; 21(9):525-6. PubMed ID: 2583676
    [No Abstract]   [Full Text] [Related]  

  • 10. Angiotensin II stimulation of teleost adrenocorticotropic hormone release: interactions with urotensin I and corticotropin-releasing factor.
    Weld MM; Fryer JN
    Gen Comp Endocrinol; 1988 Mar; 69(3):335-40. PubMed ID: 2834258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The fish neuropeptide urotensin I: its physiology and pharmacology.
    Lederis K; Fryer JN; Yulis CR
    Peptides; 1985; 6 Suppl 3():353-61. PubMed ID: 3008124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticotropin-releasing factor-like peptides increase cytosolic [Ca2+] in human epidermoid A-431 cells.
    Kiang JG
    Eur J Pharmacol; 1997 Jun; 329(2-3):237-44. PubMed ID: 9226418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the biologic actions of corticotropin-releasing factor and sauvagine.
    Brown MR; Fisher LA; Spiess J; Rivier J; Rivier C; Vale W
    Regul Pept; 1982 Jul; 4(2):107-14. PubMed ID: 6289384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of corticotropin-releasing factor-stimulated adenylate cyclase activity in rat retina.
    Olianas MC; Onali P
    J Neurochem; 1990 Jun; 54(6):1967-71. PubMed ID: 2159980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sauvagine induces release of adrenocorticotropin, beta-endorphin and corticosterone in rats.
    Negri L; Melchiorri P; Montecucchi PC; Henschen A; D'Urso R; Iellamo R; Falaschi P
    Pharmacol Res Commun; 1983 Apr; 15(4):427-38. PubMed ID: 6306700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenocorticotropic hormone-releasing activity of urotensin I and its fragments in vitro.
    Ohta N; Mochizuki T; Hoshino M; Jun L; Kobayashi H; Yanaihara N
    J Pept Res; 1997 Sep; 50(3):178-83. PubMed ID: 9309581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo and in vitro comparisons of biological activities of bovine, ovine and rat CRF (corticotrophin-releasing factor).
    Yasuda N; Yasuda Y; Aizawa T; Maruta S; Greer MA
    Acta Endocrinol (Copenh); 1984 Jun; 106(2):158-67. PubMed ID: 6328821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of CRF- and urotensin I-stimulated ACTH release from goldfish pituitary cell columns by the CRF analogue alpha-helical CRF-(9-41).
    Weld MM; Fryer JN; Rivier J; Lederis K
    Regul Pept; 1987 Dec; 19(5-6):273-80. PubMed ID: 2830643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticotropin-releasing hormone receptor expression and functional coupling in neonatal cardiac myocytes and AT-1 cells.
    Heldwein KA; Redick DL; Rittenberg MB; Claycomb WC; Stenzel-Poore MP
    Endocrinology; 1996 Sep; 137(9):3631-9. PubMed ID: 8756527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corticotropin-releasing factor (CRF) and related peptides confer neuroprotection via type 1 CRF receptors.
    Facci L; Stevens DA; Pangallo M; Franceschini D; Skaper SD; Strijbos PJ
    Neuropharmacology; 2003 Oct; 45(5):623-36. PubMed ID: 12941376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.